Retail News CRM

Tag: hershey

  • Weight-Loss Medications Boost Mint and Gum Sales: Hershey Rides the ‘Ozempic Breath’ Wave

    Weight-Loss Medications Boost Mint and Gum Sales: Hershey Rides the ‘Ozempic Breath’ Wave

    The Hershey Company recently highlighted a surprising uptick in their sales of mints and gum, which they attribute to the rising prevalence of weight-loss drugs and the consequent shift in consumers’ snacking habits. The company noted that the demand for products that freshen breath has grown in tandem with the trends toward “functional snacking” associated with the consumption of medications like Ozempic and Wegovy.

    Kirk Tanner, Hershey’s CEO, stated, “We’ve noticed a robust demand for gum and mints as they benefit from the tailwinds of functional snacking, influenced by the adoption of GLP-1 medications.” He also pointed out that the retail sales for Ice Breakers, the company’s third-largest confection brand, saw an increase of over 8% during the quarter.

    While the Hershey Company did not directly associate this trend with specific side effects, it is worth noting that some consumers taking GLP-1 medications have reported experiencing halitosis, colloquially referred to as ‘Ozempic breath’. Medical professionals suggest that this could be due to dry mouth resulting from dehydration or changes in saliva production, notwithstanding the fact that it is not officially listed as a side effect.

    This shift in consumption habits has not only impacted the mint and gum market but has also influenced other sections of the snacking industry. For instance, premium chocolate manufacturer Lindt & Sprungli has reported a marked increase in US sales among GLP-1 users. Similarly, Magnum Ice Cream Company has noticed that the trend is bolstering the demand for smaller, higher-quality snacks.

    Peter ter Kulve, the CEO of Magnum Ice Cream Company, said, “As consumers who use GLP-1s are eliminating lower-quality snacking options first, categories such as premium chocolate, premium ice cream, and protein snacks could potentially acquire a larger share of the overall snacking market.”

    Questions & Answers

    **What has been the trend in Hershey’s sales of mints and gum?**
    Hershey’s has observed an unexpected surge in their sales of mints and gum, which they attribute to changing consumption patterns due to the increased use of weight-loss drugs.

    **What are the potential reasons for the ‘bad breath’ experienced by some users of GLP-1 medications?**
    Medical professionals suggest that the bad breath experienced by some users of GLP-1 medications could be due to dry mouth resulting from dehydration or changes in saliva production.

    **How has the shift in snacking habits influenced other sectors of the snacking industry?**
    The shift in consumption patterns is supporting the demand for smaller, higher-quality snacks in other sectors of the industry. Companies like Lindt & Sprungli and Magnum Ice Cream Company have reported increased sales among users of GLP-1 medications.

  • Hershey Sales Surge Amidst Slumping Profits: Navigating Rising Cocoa Costs And Supply Chain Challenges

    Hershey Sales Surge Amidst Slumping Profits: Navigating Rising Cocoa Costs And Supply Chain Challenges

    Hershey, the confectionery giant, has registered a significant increase in sales for the second quarter despite a drastic fall in profits. This arises from the escalating costs of cocoa, supply chain, and adverse effects from commodity hedging.

    In the most recent quarter, Hershey reported net sales of US$2.61 billion, a 26 per cent surge compared to the same quarter the previous year. The growth was a result of robust demand for seasonal products, which included popular items tied to the Easter season and early Halloween shipments.

    However, despite the impressive rise in revenue, net income experienced a 65 per cent decrease, landing at $62.7 million.

    Hershey attributed the sharp decline in net income to a significant drop in gross margins, spurred by the rise in input costs and losses from mark-to-market on commodity derivatives. This was despite the strong volume growth, especially in its North American confectionery division.

    Michele Buck, President and CEO of Hershey, commented on the situation. “Our investments in brands and impactful innovation, along with effective execution, have led to solid sales and share gains in both our US confection and salty snacking businesses,” she said.

    She further added, “In the future, we are committed to delivering balanced growth and have already initiated critical steps to offset cocoa inflation through strategic pricing, improved productivity, and the use of technology for efficiency and speed.”

    In other news, Hershey recently announced the appointment of Kirk Tanner as the new President and CEO, effective from August 18, succeeding Buck.

    Questions & Answers

    What led to the growth in Hershey’s net sales?
    The increase in Hershey’s net sales was a result of strong demand for seasonal products, such as those tied to the Easter season and early Halloween shipments.

    Why did Hershey’s net income decrease despite the growth in sales?
    The decrease in net income was due to a significant drop in gross margins, which was caused by the rising input costs and mark-to-market losses on commodity derivatives.

    What measures is Hershey taking to combat cocoa inflation?
    To mitigate cocoa inflation, Hershey is implementing strategic pricing, enhancing productivity, and leveraging technology for increased efficiency and speed.